Galderma announces Completion of Phase 3 Trials of Investigational Drug targeting Facial Erythema of Rosacea Press release
Galderma receives FDA Approval for new convenient Pump Dispenser of Differin Gel, 0.3% for treatment of Acne Vulgaris Press release
Galderma Announces Availability of New Metrogel 1% Pump Dispenser for the Treatment of Papulopustular Rosacea Press release
Galderma announces positive Phase 2B Results for Investigational Compound targeting Redness of Rosacea Press release
Galderma announces positive US pivotal interim 6-month results for EMERVEL Classic Lidocaine compared to JUVEDERM Ultra Press release
AstraZeneca and Galderma enter into R&D collaboration to develop new treatments for dermatological diseases Press release
Galderma Received FDA Approval of Differin® (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation Press release
